Conmed (CNMD) Current Assets (2010 - 2026)

Conmed (CNMD) has reported Current Assets for 17 consecutive years, with $675.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets rose 2.72% year-over-year to $675.7 million; the trailing twelve-month figure through Jun 2026 stood at $675.7 million (up 2.72% YoY), and the FY2025 full-year result was $672.9 million, up 5.13% from the prior year.
• Current Assets improved to $675.7 million in Q2 2026 per CNMD's latest filing, from $670.6 million in the prior quarter.
• Across five years, Current Assets topped out at $675.7 million in Q2 2026 and bottomed at $488.3 million in Q1 2022.
• Historically, Current Assets has averaged $622.6 million across 5 years, with a median of $630.7 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Current Assets jumped 30.24% in 2022, then grew 0.52% in 2025.
• Over 5 years, Current Assets stood at $581.2 million in 2022, then increased by 5.92% to $615.6 million in 2023, then increased by 3.96% to $640.0 million in 2024, then advanced by 5.13% to $672.9 million in 2025, then advanced by 0.42% to $675.7 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $675.7 million, $670.6 million, and $672.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.